Last edition
News about "Milan Kalawadia"
Dr Reddy's Launches First-to-Market Olopatadine Ophthalmic Solution in US
With the US launch of its first-to-market OTC Olopatadine 0.7 percent eye drops, Dr Reddy’s expands access to allergy relief for itchy eyes caused by pollen and other common allergens.
Milan Kalawadia | 15/01/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members